Gordon E. Crofoot, MD, PA
Houston, Texas, United States
Medical group in Houston, Texas
3701 Kirby Dr # 1230, Houston, TX 77098
About Gordon E. Crofoot, MD, PA
"CrofootMD is a unique private medical practice which focuses on serving the needs of Houston’s members and friends of the LGBTQ community with special attention to HIV/AIDS, Hepatitis, and other infectious diseases."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Gilead Sciences
33
Sangamo Therapeutics
2
Janssen Scientific Affairs, LLC
1
Janssen Vaccines & Prevention B.V.
1
Medical College of Wisconsin
1
Clinical Trials at Gordon E. Crofoot, MD, PA
During the past decade, Gordon E. Crofoot, MD, PA conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 25 clinical trials were completed, i.e. on
average, 178.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 6 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus Raltegravir
2008-07-01
2015-04-01
Completed
724
Safety and Efficacy Study of Switching From Epzicom to Truvada
2008-07-01
2011-04-01
Completed
312
Study of the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
2009-04-01
2013-09-01
Completed
71
Safety and Efficacy of Cobicistat-boosted Atazanavir Compared to Ritonavir-boosted Atazanavir in Combination With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
2009-05-01
2015-01-01
Completed
85
Phase 1 Dose Escalation Study of Autologous T-cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases in HIV-Infected Patients
2009-12-01
2014-12-01
Completed
19
Study to Evaluate the Safety and Efficacy of Stribild Versus Atripla in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
2010-03-01
2014-09-01
Completed
707
Study to Evaluate the Safety and Efficacy of Stribild Versus Ritonavir-Boosted Atazanavir Plus Truvada in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
2010-04-01
2014-09-01
Completed
708
Safety and Efficacy of COBI-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
2010-04-01
2015-04-01
Completed
698
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Gordon E. Crofoot, MD, PA" #1 sponsor was "Gilead Sciences" with 33 trials, followed by "Sangamo Therapeutics" with 2 trials
sponsored, "Janssen Scientific Affairs, LLC" with 1 trials sponsored, "Janssen Vaccines & Prevention B.V." with 1 trials sponsored and "Medical College of Wisconsin"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Gordon E. Crofoot, MD, PA"
#1 collaborator was "Gordon Crofoot MD PA" with 1 trials as a collaborator, "Janssen Research & Development, LLC" with 1 trials as a collaborator, "M.D. Anderson Cancer Center" with 1 trials as a collaborator, "The University of Texas Health Science Center, Houston" with 1 trials as a collaborator and "University of Chicago" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at Gordon E. Crofoot, MD, PA
According to Clinical.Site data, the most researched conditions in "Gordon E. Crofoot, MD, PA" are
"HIV Infections" (16 trials), "HIV-1 Infection" (12 trials), "HIV" (10 trials), "Acquired Immunodeficiency Syndrome" (7 trials) and "HIV Infection" (3 trials). Many other conditions were trialed in "Gordon E. Crofoot, MD, PA" in a lesser frequency.
Clinical Trials Intervention Types at Gordon E. Crofoot, MD, PA
Most popular intervention types in "Gordon E. Crofoot, MD, PA" are "Drug" (34 trials), "Genetic" (2 trials), "Behavioral" (1 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "E/C/F/TAF" (9 trials), "FTC/TDF" (8 trials), "B/F/TAF" (6 trials), "Stribild" (6 trials) and "COBI" (5 trials). Other intervention names were less common.
Clinical Trials Genders at Gordon E. Crofoot, MD, PA
The vast majority of trials in "Gordon E. Crofoot, MD, PA" are
37 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Gordon E. Crofoot, MD, PA
Currently, there are NaN active trials in "Gordon E. Crofoot, MD, PA".
undefined are not yet recruiting,
undefined are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 34 completed trials in Gordon E. Crofoot, MD, PA,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Gordon E. Crofoot, MD, PA, 3 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 29 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".